Resource Center

Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
Quotient Sciences Logo
GLP1, Oral Peptides, Dr. Andy Lewis

On-Demand: A Deep Dive Into the CMC, Technology and Financial Aspects of Successful Development of an Orally Delivered GLP-1

31 October 2024 Learn more

51 - 60 of 214 results

Scientific Poster, First-in-Human, Translational Pharmaceutics, Clinical Trial Manufacturing, Formulation Development
A First-in-Human (FIH) Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses, and Alternative Formulations of R941552 (R552): A selective Receptor Interacting Protein 1 (RIP1) Kinase Inhibitor
24 March 2022
Download Now
Peer Reviewed Publication, Drug Product Optimization
A Phase 1 Pharmacokinetic Drug Interaction Study of Belumosudil Coadministered With CYP3A4 Inhibitors and Inducers and Proton Pump Inhibitors
15 March 2022
Download Now
Peer Reviewed Publication, Drug Product Optimization
Phase 1 Studies to Evaluate the Food Effect and Relative Bioavailability of Tablet and Capsule Formulations of Belumosudil in Healthy Adult Subjects
15 March 2022
Download Now
Peer Reviewed Publication, Drug Product Optimization
Absolute Bioavailability, Mass Balance, and Metabolic Profiling Assessment of [14C]-Belumosudil in Healthy Men: A Phase 1, Open-Label, 2-Part Study
15 March 2022
Download Now
Peer Reviewed Publication, Drug Product Optimization
ACCP: A Phase 1 Pharmacokinetic Drug Interaction Study of Belumosudil Coadministered With CYP3A4 Inhibitors and Inducers and Proton Pump Inhibitors
7 March 2022
Download Now
Peer Reviewed Publication, Materials Science
Controlled synthesis of SPION@SiO2 nanoparticles using design of experiments
13 February 2022
Download Now
Peer Reviewed Publication, Human ADME, Clinical Pharmacology, First-in-Human
Astrazeneca - Characterization of Clinical ADME & Pharmacokinetics of Velsecorat Using an IV Microtracer Combined with an Inhaled Dose in Healthy Subjects
2 February 2022
Download Now
Peer Reviewed Publication, Modified Release, Formulation Development
Development of a Once‑Daily Modified‑Release Formulation for the Short Half‑Life RIPK1 Inhibitor GSK2982772 using DiffCORE Technology
10 January 2022
Download Now
Peer Reviewed Publication, Clinical Pharmacology
Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects
3 January 2022
Download Now
Scientific Poster, First-in-Human
An integrated radiolabelled study to determine the mass balance, metabolite profile and identification, and absolute bioavailability of nolasiban in healthy female subjects
22 December 2021
Download Now
Get in touch
Humanity can't afford to wait, so neither can we.
Let's talk